GL1X · GenesisL1 explorer

Research workbench

Catalytic domain of mouse 2',3'-cyclic nucleotide 3'- phosphodiesterase, with mutation T311A

Analyse Catalytic domain of mouse 2',3'-cyclic nucleotide 3'- phosphodiesterase, with… in the GL1X research workbench: secondary structure, accessibility, pockets, interfaces, conservation, variants, modifications, peptides, crosslinks and neighbours on the 3D structure.

PDB
4WDE
Type
protein
Length
427 residues
Chains
2
Method
x-ray diffraction
Collection
MolNFT v1 / PDB
Contract
0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
Owner
0x3396CDB397284571d12822B4ae1189a8E22AAAAA
Molecule
2',3'-cyclic-nucleotide 3'-phosphodiesterase
EC
3.1.4.37
UniProt
P16330
Pockets
3 · best druggability 0.71

Structure

x-ray diffraction · 2 distinct chains · 30% helix, 30% strand (DSSP).

ChainMoleculeTypeResiduesSecondary structureUniProt
A2',3'-cyclic-nucleotide 3'-phosphodiesterase (EC 3.1.4.37)protein21531% helix, 30% strandP16330
B2',3'-cyclic-nucleotide 3'-phosphodiesterase (EC 3.1.4.37)protein21230% helix, 31% strandP16330

Ligands and binding sites

  • GOL · Glycerol · additive · chains A

Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.

Pockets

3 pockets found on a 1 Å grid, 3 with a druggability of 0.5 or more.

PocketVolume (ų)DruggabilityBuriednessLining residuesInside
16910.710.7858empty
24670.640.7747GOL
33270.570.7639empty

Interfaces

1 interface between chains.

  • A–B · 352 Ų buried · 8 hydrogen bonds · protein-protein

Compared structures

  • 4WDE · Catalytic domain of mouse 2',3'-cyclic nucleotide 3'- phosphodiesterase, with mutation… · the same entry in another collection · chain A against A, TM-score 1.00
  • P16330 · AlphaFold monomer V2.0 prediction for 2',3'-cyclic-nucleotide 3'-phosphodiesterase… · a predicted model of the same protein · chain B against A, TM-score 0.97

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.